Low dose radiation induced senescence of human mesenchymal stromal cells and impaired the autophagy process

Oncotarget

Volumn 6, Issue 10, 2015, Pages 8155-8166

  Alessio, Nicola ^b   Del Gaudio, Stefania ^b   Capasso, Stefania ^b   Di Bernardo, Giovanni ^b   Cappabianca, Salvatore ^d   Cipollaro, Marilena ^b   Peluso, Gianfranco ^c   Galderisi, Umberto ^a,b,c  

^a TEMPLE UNIVERSITY   (United States)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c CNR   (Italy)

^d University of Naples   (Italy)

Author keywords

Mesenchymal stem cells; Radiation; Senescence

Indexed keywords

ATM PROTEIN; HISTONE H2AX;

ADULT; ARTICLE; AUTOPHAGY; CELL CYCLE ARREST; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA END JOINING REPAIR; DNA REPAIR; HUMAN; HUMAN CELL; IONIZING RADIATION; MESENCHYMAL STROMA CELL; NORMAL HUMAN; RADIOSENSITIVITY; SENESCENCE; SIGNAL TRANSDUCTION; ADOLESCENT; APOPTOSIS; CELL AGING; CELL CYCLE; CYTOLOGY; METABOLISM; RADIATION RESPONSE; YOUNG ADULT;

ADOLESCENT; ADULT; APOPTOSIS; AUTOPHAGY; CELL AGING; CELL CYCLE; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MESENCHYMAL STROMAL CELLS; S PHASE; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84928413006     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2692     Document Type: Article

References (49)

1. Rando TA. Stem cells, ageing and the quest for immortality. Nature. 2006; 441:1080-1086.
2. Sperka T, Wang J, Rudolph KL. DNA damage checkpoints in stem cells, ageing and cancer. Nature reviews Molecular cell biology. 2012; 13:579-590.
3. Capasso S, Alessio N, Di Bernardo G, Cipollaro M, Melone MA, Peluso G, Giordano A, Galderisi U. Silencing of RB1 and RB2/P130 during adipogenesis of bone marrow stromal cells results in dysregulated differentiation. Cell cycle. 2014; 13:482-490.
4. Chua HL, Plett PA, Sampson CH, Joshi M, Tabbey R, Katz BP, MacVittie TJ, Orschell CM. Long-term hematopoietic stem cell damage in a murine model of the hematopoietic syndrome of the acute radiation syndrome. Health physics. 2012; 103:356-366.
5. Cmielova J, Havelek R, Soukup T, Jiroutova A, Visek B, Suchanek J, Vavrova J, Mokry J, Muthna D, Bruckova L, Filip S, English D, Rezacova M. Gamma radiation induces senescence in human adult mesenchymal stem cells from bone marrow and periodontal ligaments. International journal of radiation biology. 2012; 88:393-404.
6. Fekete N, Erle A, Amann EM, Furst D, Rojewski MT, Langonne A, Sensebe L, Schrezenmeier H, Schmidtke-Schrezenmeier G. Effect of High-Dose Irradiation on Human Bone-Marrow-Derived Mesenchymal Stromal Cells. Tissue engineering Part C, Methods. 2014.
7. Francois S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, Semont A, Frick J, Sache A, Bouchet S, Thierry D, Gourmelon P, Gorin NC, Chapel A. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem cells. 2006; 24:1020-1029.
8. Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld JL, Deeg HJ. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. International journal of radiation oncology, biology, physics. 1995; 31:1319-1339.
9. Wang Y, Schulte BA, Zhou D. Hematopoietic stem cell senescence and long-term bone marrow injury. Cell cycle. 2006; 5:35-38.
10. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, Shah ND, Nasir K, Einstein AJ, Nallamothu BK. Exposure to low-dose ionizing radiation from medical imaging procedures. The New England journal of medicine. 2009; 361:849-857.
11. Manda K, Kavanagh JN, Buttler D, Prise KM, Hildebrandt G. Low dose effects of ionizing radiation on normal tissue stem cells. Mutation research Reviews in mutation research. 2014;.
12. Barba M, Mazza A, Guerriero C, Di Maio M, Romeo F, Maranta P, Marino IR, Paggi MG. Giordano A. Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy. Cancer biology & therapy. 2011; 12:106-111.
13. Fazzo L, De Santis M, Mitis F, Benedetti M, Martuzzi M, Comba P, Fusco M. Ecological studies of cancer incidence in an area interested by dumping waste sites in Campania (Italy). Annali dell'Istituto superiore di sanita. 2011; 47:181-191.
14. Jin YW, Na YJ, Lee YJ, An S, Lee JE, Jung M, Kim H, Nam SY, Kim CS, Yang KH, Kim SU, Kim WK, Park WY, Yoo KY, Kim CS, Kim JH. Comprehensive analysis of time-and dose-dependent patterns of gene expression in a human mesenchymal stem cell line exposed to low-dose ionizing radiation. Oncology reports. 2008; 19:135-144.
15. Liang X, So YH, Cui J, Ma K, Xu X, Zhao Y, Cai L, Li W. The low-dose ionizing radiation stimulates cell proliferation via activation of the MAPK/ERK pathway in rat cultured mesenchymal stem cells. Journal of radiation research. 2011; 52:380-386.
16. Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Cancer research. 2014; 74:647-651.
17. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. International journal of radiation oncology, biology, physics. 2001; 49(2):379-389.
18. Martin LM, Marples B, Lynch TH, Hollywood D, Marignol L. Exposure to low dose ionising radiation: molecular and clinical consequences. Cancer letters. 2013; 338:209-218.
19. Wouters BG, Skarsgard LD. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the "adaptive response" and cannot be explained by a subpopulation of sensitive cells. Radiation research. 1997; 148:435-442.
20. Altmeyer A, Josset E, Denis JM, Gueulette J, Slabbert J, Mutter D, Noel G, Bischoff P. The mTOR inhibitor RAD001 augments radiation-induced growth inhibition in a hepatocellular carcinoma cell line by increasing autophagy. International journal of oncology. 2012; 41:1381-1386.
21. Lomonaco SL, Finniss S, Xiang C, Decarvalho A, Umansky F, Kalkanis SN, Mikkelsen T, Brodie C. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. International journal of cancer Journal international du cancer. 2009; 125:717-722.
22. Thorburn A, Thamm DH, Gustafson DL. Autophagy and cancer therapy. Molecular pharmacology. 2014; 85:830-838.
23. Gewirtz DA. Autophagy and senescence: a partnership in search of definition. Autophagy. 2013; 9:808-812.
24. White E, Lowe SW. Eating to exit: autophagy-enabled senescence revealed. Genes & development. 2009; 23:784-787.
25. Mizushima N. Methods for monitoring autophagy. The international journal of biochemistry & cell biology. 2004; 36:2491-2502.
26. Lee JH, Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene. 2007; 26:7741-7748.
27. Freeman AK, Monteiro AN. Phosphatases in the cellular response to DNA damage. Cell communication and signaling: CCS. 2010; 8:27.
28. Jansen RL, Hupperets PS, Arends JW, Joosten-Achjanie SR, Volovics A, Schouten HC, Hillen HF. MIB-1 labelling index is an independent prognostic marker in primary breast cancer. British journal of cancer. 1998; 78:460-465.
29. Kakarougkas A, Ismail A, Klement K, Goodarzi AA, Conrad S, Freire R, Shibata A, Lobrich M, Jeggo PA. Opposing roles for 53BP1 during homologous recombination. Nucleic acids research. 2013; 41: 9719-9731.
30. Polo SE, Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes & development. 2011; 25:409-433.
31. Shibata A, Conrad S, Birraux J, Geuting V, Barton O, Ismail A, Kakarougkas A, Meek K, Taucher-Scholz G, Lobrich M, Jeggo PA. Factors determining DNA doublestrand break repair pathway choice in G2 phase. The EMBO journal. 2011; 30:1079-1092.
32. Fu S, Yang Y, Das TK, Yen Y, Zhou BS, Zhou MM, Ohlmeyer M, Ko EC, Cagan R, Rosenstein BS, Chen SH, Kao J. gamma-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers. PloS one. 2012; 7:e38465.
33. Kao J, Milano MT, Javaheri A, Garofalo MC, Chmura SJ, Weichselbaum RR, Kron SJ. gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy. Current cancer drug targets. 2006; 6:197-205.
34. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH, Preston DL, Preston RJ, Puskin JS, Ron E, Sachs RK, Samet JM, Setlow RB, Zaider M. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100:13761-13766.
35. Singh S, Kloss FR, Brunauer R, Schimke M, Jamnig A, Greiderer-Kleinlercher B, Klima G, Rentenberger J, Auberger T, Hachl O, Rasse M, Gassner R, Lepperdinger G. Mesenchymal stem cells show radioresistance in vivo. Journal of cellular and molecular medicine. 2012; 16:877-887.
36. Sugrue T, Lowndes NF, Ceredig R. Mesenchymal stromal cells: radio-resistant members of the bone marrow. Immunology and cell biology. 2013; 91:5-11.
37. Wang D, Jang DJ. Protein kinase CK2 regulates cytoskeletal reorganization during ionizing radiationinduced senescence of human mesenchymal stem cells. Cancer research. 2009; 69:8200-8207.
38. Nicolay NH, Sommer E, Lopez R, Wirkner U, Trinh T, Sisombath S, Debus J, Ho AD, Saffrich R, Huber PE. Mesenchymal stem cells retain their defining stem cell characteristics after exposure to ionizing radiation. International journal of radiation oncology, biology, physics. 2013; 87:1171-1178.
39. Hou J, Han ZP, Jing YY, Yang X, Zhang SS, Sun K, Hao C, Meng Y, Yu FH, Liu XQ, Shi YF, Wu MC, Zhang L, Wei LX. Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells. Cell death & disease. 2013; 4:e844.
40. Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TORdriven aging. Aging. 2012; 4:159-165.
41. Leontieva OV, Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging. 2010; 2:924-935.
42. Iglesias-Bartolome R, Gutkind SJ. Exploiting the mTOR paradox for disease prevention. Oncotarget. 2012; 3:1061-1063.
43. Luo Y, Li L, Zou P, Wang J, Shao L, Zhou D, Liu L. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence. Transplantation. 2014; 97:20-29.
44. Rodier F, Campisi J. Four faces of cellular senescence. The Journal of cell biology. 2011; 192:547-556.
45. Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and disease. The Journal of cell biology. 2010; 189:1059-1070.
46. Galderisi U, Giordano A. The gap between the physiological and therapeutic roles of mesenchymal stem cells. Medicinal research reviews. 2014; 34: 1100-1126.
47. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8:315-317.
48. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nature protocols. 2009; 4:1798-1806.
49. Pochampally R. Colony forming unit assays for MSCs. Methods in molecular biology. 2008; 449:83-91.